199 related articles for article (PubMed ID: 34282237)
1. Endotrophin and C6Ma3, serological biomarkers of type VI collagen remodelling, reflect endoscopic and clinical disease activity in IBD.
Lindholm M; Godskesen LE; Manon-Jensen T; Kjeldsen J; Krag A; Karsdal MA; Mortensen JH
Sci Rep; 2021 Jul; 11(1):14713. PubMed ID: 34282237
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
3. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
4. C-terminal proteolysis of the collagen VI α3 chain by BMP-1 and proprotein convertase(s) releases endotrophin in fragments of different sizes.
Heumüller SE; Talantikite M; Napoli M; Armengaud J; Mörgelin M; Hartmann U; Sengle G; Paulsson M; Moali C; Wagener R
J Biol Chem; 2019 Sep; 294(37):13769-13780. PubMed ID: 31346034
[TBL] [Abstract][Full Text] [Related]
5. Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort.
Rønnow SR; Langholm LL; Karsdal MA; Manon-Jensen T; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ; Sand JMB
Respir Res; 2020 Jul; 21(1):202. PubMed ID: 32731895
[TBL] [Abstract][Full Text] [Related]
6. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Biomarkers of Extracellular Matrix Remodeling and Disease Activity in Crohn's Disease and Ulcerative Colitis.
Domislovic V; Høg Mortensen J; Lindholm M; Kaarsdal MA; Brinar M; Barisic A; Manon-Jensen T; Krznaric Z
J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233775
[TBL] [Abstract][Full Text] [Related]
9. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
10. Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.
Bodelier AG; Pierik MJ; Lenaerts K; de Boer E; Olde Damink SW; Hameeteman WM; Masclee AA; Jonkers DM
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):807-13. PubMed ID: 26919325
[TBL] [Abstract][Full Text] [Related]
11. A Fragment of Collagen Type VI alpha-3 chain is Elevated in Serum from Patients with Gastrointestinal Disorders.
Holm Nielsen S; Mortensen JH; Willumsen N; Rasmussen DGK; Mogensen DJ; Di Sabatino A; Mazza G; Jørgensen LN; Giuffrida P; Pinzani M; Klinge L; Kjeldsen J; Leeming DJ; Karsdal MA; Genovese F
Sci Rep; 2020 Apr; 10(1):5910. PubMed ID: 32245981
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.
Farkas K; Saródi Z; Bálint A; Földesi I; Tiszlavicz L; Szűcs M; Nyári T; Tajti J; Nagy F; Szepes Z; Bor R; Annaházi A; Róka R; Molnár T
J Crohns Colitis; 2015 Mar; 9(3):231-7. PubMed ID: 25585596
[TBL] [Abstract][Full Text] [Related]
13. Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes.
Karsdal MA; Henriksen K; Genovese F; Leeming DJ; Nielsen MJ; Riis BJ; Christiansen C; Byrjalsen I; Schuppan D
Diabetologia; 2017 Jan; 60(1):50-59. PubMed ID: 27631136
[TBL] [Abstract][Full Text] [Related]
14. Serum galectins as potential biomarkers of inflammatory bowel diseases.
Yu TB; Dodd S; Yu LG; Subramanian S
PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
[TBL] [Abstract][Full Text] [Related]
15. Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn's Disease.
Alexdottir MS; Bourgonje AR; Karsdal MA; Pehrsson M; Loveikyte R; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Faber KN; Dijkstra G; Mortensen JH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897710
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV.
Dold L; Nielsen MJ; Praktiknjo M; Schwarze-Zander C; Boesecke C; Wasmuth JC; Bischoff J; Rockstroh JK; Karsdal MA; Spengler U; Trebicka J; Strassburg CP; Leeming DJ; Langhans B
BMC Infect Dis; 2023 Jan; 23(1):52. PubMed ID: 36694115
[TBL] [Abstract][Full Text] [Related]
17. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.
van Haaften WT; Mortensen JH; Karsdal MA; Bay-Jensen AC; Dijkstra G; Olinga P
Aliment Pharmacol Ther; 2017 Jul; 46(1):26-39. PubMed ID: 28481042
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease.
Aomatsu T; Yoden A; Matsumoto K; Kimura E; Inoue K; Andoh A; Tamai H
Dig Dis Sci; 2011 Aug; 56(8):2372-7. PubMed ID: 21394462
[TBL] [Abstract][Full Text] [Related]
19. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
[TBL] [Abstract][Full Text] [Related]
20. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
Falvey JD; Hoskin T; Meijer B; Ashcroft A; Walmsley R; Day AS; Gearry RB
Inflamm Bowel Dis; 2015 Apr; 21(4):824-31. PubMed ID: 25738372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]